Iowa abortion ban: State’s maternity care deserts continue to grow | CNN
Dr. Emily Boevers is a practicing OGBYN at a critical access hospital in a rural town in Iowa about ten miles from the farm she grew up on.
Related Articles
Highlights from the Alzheimer’s Association International Conference
This Medical News article is an interview about the latest findings presented at the recent Alzheimer’s Association International Conference.
At Catholic Hospitals, a Mission of Charity Runs Up Against High Care Costs for Patients – KFF Health News
Many Catholic health systems, which are tax-exempt, pay their executives millions and can charge some of the highest prices around — while critics say they…
Biosimilars in Multiple Sclerosis: Are We Ready?
How biosimilars can increase access to biologics for patients with multiple sclerosis (MS).
Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis
Objective To provide a comprehensive assessment of various fractionation schemes in radiation therapy for breast cancer, with a focus on side effects, cosmesis, quality of…
Polaris Dawn: Billionaire completes first private spacewalk
“From here Earth sure looks like a perfect world,” said the first private citizen to perform a spacewalk
Lucy Letby inquiry: ‘Tubes dislodged’ during placement at other hospital
Lucy Letby worked two placements at Liverpool Women’s Hospital in 2012 and 2015.
Gilead’s twice-yearly antiviral protects against HIV infection in second large trial
Gilead said Thursday that its twice-yearly antiviral reduced the risk of HIV infections by 96% compared to an expected rate of infection in a second
Ice or Heat: What’s Better for Soothing Arthritis Pain?
If your arthritis is causing you pain, stiffness and inflammation, you may turn to a heating pad or ice pack to get relief. But is…
Gilead’s twice-yearly antiviral protects against HIV infection in second large trial
Gilead said Thursday that its twice-yearly antiviral reduced the risk of HIV infections by 96% compared to an expected rate of infection in a second
